Moon­Lake out­lines more da­ta in pso­ri­at­ic arthri­tis as it preps for piv­otal tri­als: #AAD24

Moon­Lake Im­munother­a­peu­tics on Sun­day tout­ed up­dat­ed da­ta from a Phase II pso­ri­at­ic arthri­tis tri­al that­was met with skep­ti­cism last year, and has now out­lined its …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER